← 뒤로

Soft-Tissue Reconstruction in Progressive Hemifacial Atrophy: Current Evidence and Future Directions.

Plastic and reconstructive surgery 2022 Vol.150(3) p. 607-617

Abi-Rafeh J, Jaberi M, Cattelan L, Aljerian A, Gilardino MS

관련 도메인

Abstract

[BACKGROUND] Progressive hemifacial atrophy is a rare disorder characterized by gradual unilateral soft-tissue atrophy in the face, which may also include clinically significant degeneration of underlying muscle and bone. In recent years, there has been a growing body of evidence regarding different soft-tissue reconstructive strategies in progressive hemifacial atrophy and the impact of intervention timing on disease progression. This article provides a comprehensive synthesis of the latest evidence to guide optimal management.

[METHODS] A comprehensive multidatabase search was performed through April of 2020 using relevant search terms to identify clinical studies. Outcomes, complications, and disease- and patient-related indications pertaining to different soft-tissue reconstructive strategies in progressive hemifacial atrophy were collected and critically appraised.

[RESULTS] Thirty-five articles reporting on a total of 824 progressive hemifacial atrophy patients were evaluated; 503 patients (61 percent) were managed by microvascular free flaps, 302 patients (37 percent) were managed by autologous fat grafts, and 19 patients (2 percent) were managed by pedicled flaps. A detailed synthesis of outcomes is presented in this article, as is a comparative evaluation of different microvascular free flap options.

[CONCLUSIONS] Soft-tissue reconstruction in progressive hemifacial atrophy remains an evolving field. Operative decision-making is often multifaceted, and guided by specific volumetric, aesthetic, and functional deficiencies. Serial fat grafting is the primary modality used for patients with mild soft-tissue atrophy, whereas microvascular free flaps widely remain the treatment of choice for reconstruction of large-volume defects. There exists a growing role of graft supplementation to improve fat graft survival, whereas recent evidence demonstrates that early intervention may help curb disease progression.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microvascular 미세수술 dict 3
시술 free flap 피판재건술 dict 1
해부 soft-tissue scispacy 1
해부 muscle scispacy 1
해부 bone scispacy 1
해부 fat grafts scispacy 1
해부 flap scispacy 1
해부 fat scispacy 1
해부 flaps scispacy 1
해부 graft scispacy 1
해부 fat graft scispacy 1
합병증 flaps scispacy 1
합병증 pedicled flaps scispacy 1
약물 [CONCLUSIONS] Soft-tissue scispacy 1
질환 Hemifacial Atrophy C0015458
Facial Hemiatrophy
scispacy 1
질환 soft-tissue atrophy scispacy 1
질환 disease scispacy 1
기타 Soft-Tissue scispacy 1

MeSH Terms

Adipose Tissue; Atrophy; Disease Progression; Facial Hemiatrophy; Free Tissue Flaps; Humans; Plastic Surgery Procedures

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (5)

관련 논문